Wang Hua, Tang Zhaosheng, Li Xu, Hu Bo, Feng Bo
Department of Endocrinology, East Hospital, Tongji University School of Medicine, Shanghai, China.
J Diabetes. 2014 Nov;6(6):541-6. doi: 10.1111/1753-0407.12188. Epub 2014 Sep 6.
The aim of the present study was to assess the effect of glucose metabolic status on the progression of coronary artery lesions in patients with coronary artery disease (CAD).
Two hundred and ninety-eight CAD patients who underwent coronary angiography were included in the study; follow-up angiography was performed after 9-15 months. The Gensini score, SYNTAX score, and the number of diseased vessels (at baseline and follow-up, as well as the change from baseline to follow-up) were used to determine the severity and progression of coronary artery lesions. The relationship between glucose metabolic status and progression of coronary artery lesions was investigated. Based on results of an oral glucose tolerance test, patients were divided into three groups: normal glucose tolerance (NGT); impaired glucose regulation(IGR); and type 2 diabetes mellitus (DM).
Compared with the NGT group, changes (from baseline to follow-up) in the Gensini score, SYNTAX score, and the number of diseased vessels were significantly higher in the IGR and DM groups. There were no significant differences between the IGR and DM groups. Multivariate regression analysis suggested abnormal glucose metabolism was an independent risk factor for greater changes in the Gensini and SYNTAX scores, as well as for a greater number of diseased vessels.
Greater progression of coronary artery lesions is seen in patients with abnormal glucose metabolism (DM and/or IGR), even when levels of HbA1c are on target.
本研究旨在评估糖代谢状态对冠心病(CAD)患者冠状动脉病变进展的影响。
本研究纳入了298例行冠状动脉造影的CAD患者;在9 - 15个月后进行随访血管造影。采用Gensini评分、SYNTAX评分以及病变血管数量(基线和随访时,以及从基线到随访的变化)来确定冠状动脉病变的严重程度和进展情况。研究了糖代谢状态与冠状动脉病变进展之间的关系。根据口服葡萄糖耐量试验结果,将患者分为三组:糖耐量正常(NGT);糖调节受损(IGR);以及2型糖尿病(DM)。
与NGT组相比,IGR组和DM组的Gensini评分、SYNTAX评分以及病变血管数量(从基线到随访)的变化显著更高。IGR组和DM组之间无显著差异。多因素回归分析表明,糖代谢异常是Gensini和SYNTAX评分变化更大以及病变血管数量更多的独立危险因素。
即使糖化血红蛋白(HbA1c)水平达标,糖代谢异常(DM和/或IGR)患者的冠状动脉病变进展也更明显。